Oscar Health (NYSE:OSCR) Shares Gap Down to $14.69

Shares of Oscar Health, Inc. (NYSE:OSCR - Get Free Report) gapped down prior to trading on Tuesday . The stock had previously closed at $14.69, but opened at $13.97. Oscar Health shares last traded at $14.11, with a volume of 471,736 shares changing hands.

Analysts Set New Price Targets

OSCR has been the subject of a number of recent research reports. Wells Fargo & Company upped their price objective on shares of Oscar Health from $12.00 to $20.00 and gave the stock an "overweight" rating in a report on Thursday, February 15th. TheStreet raised Oscar Health from a "d" rating to a "c-" rating in a report on Wednesday, February 21st. The Goldman Sachs Group upped their target price on Oscar Health from $8.00 to $16.00 and gave the stock a "neutral" rating in a research report on Friday, February 9th. Finally, Raymond James began coverage on Oscar Health in a report on Friday, March 22nd. They set an "outperform" rating and a $20.00 price target on the stock. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $13.50.

Oscar Health Stock Down 5.2 %

The firm has a 50-day moving average of $14.83 and a two-hundred day moving average of $9.99. The firm has a market cap of $3.20 billion, a price-to-earnings ratio of -11.73 and a beta of 1.79. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.37.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Wednesday, February 7th. The company reported ($0.66) EPS for the quarter, topping analysts' consensus estimates of ($0.74) by $0.08. Oscar Health had a negative return on equity of 29.99% and a negative net margin of 4.62%. The company had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same period in the previous year, the company earned ($1.05) earnings per share. The company's quarterly revenue was up 43.9% compared to the same quarter last year. As a group, sell-side analysts predict that Oscar Health, Inc. will post -0.23 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Charles Schwab Investment Management Inc. grew its position in Oscar Health by 19.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,125,355 shares of the company's stock worth $6,268,000 after buying an additional 182,206 shares in the last quarter. Graham Capital Management L.P. acquired a new stake in shares of Oscar Health during the 3rd quarter worth approximately $894,000. Versor Investments LP acquired a new stake in shares of Oscar Health during the 3rd quarter worth approximately $553,000. Dark Forest Capital Management LP bought a new stake in shares of Oscar Health during the third quarter valued at approximately $581,000. Finally, Algert Global LLC raised its stake in shares of Oscar Health by 160.1% in the third quarter. Algert Global LLC now owns 147,567 shares of the company's stock valued at $822,000 after purchasing an additional 90,840 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company's stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.